Press Release – New York, NY – June 24, 2022 – Sichenzia Ross Ference LLP announced today that it represented Network 1 Financial Securities, Inc. as sole underwriter in the initial public offering of …
Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $19.5 Million Private Placement Offering
Press Release – New York, NY – May 1, 2022 – Sichenzia Ross Ference LLP today announced that it represented Sunshine Biopharma, Inc., a pharmaceutical company focused on the research, development and …
Sichenzia Ross Ference LLP Represents Splash Beverage Group, Inc. in $9.2 Million Underwritten Public Offering
Press Release – New York, NY – February 18, 2022 – Sichenzia Ross Ference LLP today announced that it represented Splash Beverage Group, Inc. (NYSE American: SBEV), a portfolio company of leading …
Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to MAINZ BIOMED N.V. in $25.875 Million U.S. Follow-On Public Offering
Press Release – New York, NY – January 28, 2022 – Sichenzia Ross Ference LLP congratulates MAINZ BIOMED N.V. (the “Company”) (NASDAQ: MYNZ ), a molecular genetics diagnostic company specializing in …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd.
Press Release – New York, NY – December 30, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of BiondVax …
Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $172.5 Million Upsized Public Offering Underwritten by Goldman Sachs and Jefferies
Press Release – New York, NY – December 14, 2021 – Sichenzia Ross Ference LLP today announced that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company …
